B. Yulug Et Al. , "18F-FDG-PET correlates of impulse control disorder in a diabetic patient," Endocrine, Metabolic and Immune Disorders - Drug Targets , vol.16, no.3, pp.224-227, 2016
Yulug, B. Et Al. 2016. 18F-FDG-PET correlates of impulse control disorder in a diabetic patient. Endocrine, Metabolic and Immune Disorders - Drug Targets , vol.16, no.3 , 224-227.
Yulug, B., HANOĞLU, L., Tavlı, A. M., ÇAKIR, T., KHANMAMMADOV, E., & OLMUŞÇELİK, O., (2016). 18F-FDG-PET correlates of impulse control disorder in a diabetic patient. Endocrine, Metabolic and Immune Disorders - Drug Targets , vol.16, no.3, 224-227.
Yulug, Burak Et Al. "18F-FDG-PET correlates of impulse control disorder in a diabetic patient," Endocrine, Metabolic and Immune Disorders - Drug Targets , vol.16, no.3, 224-227, 2016
Yulug, Burak Et Al. "18F-FDG-PET correlates of impulse control disorder in a diabetic patient." Endocrine, Metabolic and Immune Disorders - Drug Targets , vol.16, no.3, pp.224-227, 2016
Yulug, B. Et Al. (2016) . "18F-FDG-PET correlates of impulse control disorder in a diabetic patient." Endocrine, Metabolic and Immune Disorders - Drug Targets , vol.16, no.3, pp.224-227.
@article{article, author={Burak YULUĞ Et Al. }, title={18F-FDG-PET correlates of impulse control disorder in a diabetic patient}, journal={Endocrine, Metabolic and Immune Disorders - Drug Targets}, year=2016, pages={224-227} }